Study provides new look at why rare cancer often evades treatments
Por um escritor misterioso
Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Advances in Lung Cancer Treatment Using Nanomedicines
Organoids study finds potential new treatment for pulmonary neuroendocrine tumors
Precision therapy for RET-altered cancers with RET inhibitors: Trends in Cancer
How cancer doesn't happen - Part 2
Current Clinical Applications of In Vivo Gene Therapy with AAVs: Molecular Therapy
IJMS, Free Full-Text
Cancers, Free Full-Text
Immunotherapy Drug is Well Tolerated in Lung Cancer Patients with Limited Physical Function, Study Suggests - UPMC & Pitt Health Sciences News Blog
Count Me In launches a rare cancer research project to engage leiomyosarcoma patients and families
Outsmart Your Cancer: Alternative by Pierce, Tanya Harter
Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing
Aretha Franklin's Cancer Diagnosis Clarified - Cancer Health
Study provides new look at why rare cancer often evades treatments
Scientists reveal how proteins drive growth of multiple cancer types – Washington University School of Medicine in St. Louis
CAR T-cell therapy turns blood into a cancer-fighting weapon
de
por adulto (o preço varia de acordo com o tamanho do grupo)